A study evaluating the safety of dose-dense EC with pegfilgrastim.
Phase 2
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000020834
- Lead Sponsor
- Fukuyama city hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1 allergic for G-CSF 2 a case of active infection 3 pregnancy or breast-feeding 4 severe comobidity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rate of severe adverse event
- Secondary Outcome Measures
Name Time Method rate of febrile neutropenia, oher adverse event